Table 2.
Comparison of general information, biochemical indicators, blood routine between two group patients.
| Variable | Normal + Low risk n = 69 | Medium risk + High risk n = 44 | P | |
|---|---|---|---|---|
| General information | AGE(y) | 59.43 ± 7.65 | 59.88 ± 8.09 | 0.894 |
| HTN history | 37 | 19 | 0.281 | |
| Smoking history | 30 | 23 | 0.363 | |
| Sex | M = 40 F = 29 | M = 32 F = 12 | 0.113 | |
| BMI (kg/m2) | 25.75 ± 2.94 | 24.80 ± 3.87 | 0.133 | |
| HR (60–100)/min | 71.26 ± 9.25 | 74.86 ± 11.53 | 0.046* | |
| SBP (90–120) mmHg | 135 (117.5, 152.5) | 125.5 (114, 137) | 0.097 | |
| DBP (60–90) mmHg | 78 (72.5, 89) | 75 (70, 79.7) | 0.014* | |
| MAP (70–105) mmHg | 98.51 ± 14.47 | 92.26 ± 10.99 | 0.031* | |
| Heart | CK (0–200) U/L | 77 (55, 118.5) | 149.5 (75.5, 1363.5) | 0.000** |
| CK-MB (0–25) U/L | 14 (9, 18) | 20.5 (11.5, 113.7) | 0.001** | |
| LDH (0–220) U/L | 179 (157, 220) | 245.5 (183.5, 578.5) | 0.000** | |
| HBDH (0–295) U/L | 145 (128.5, 175) | 236 (142.5, 492.5) | 0.000** | |
| Kidney | BUN (2.5–7.0) mmol/L | 5.2 (4.3, 5.95) | 5.3 (4.5, 6.5) | 0.360 |
| CREA (75–115) mmol/L | 65 (53.5, 72) | 68 (60, 79.5) | 0.026* | |
| Liver | AST (0–40) U/L | 19 (16, 24.5) | 45.5 (22, 181.7) | 0.000** |
| ALT (0–40) U/L | 18 (14, 27) | 39.5 (21, 55.75) | 0.000** | |
| TB (5.1–25.6) umol/L | 11.1 (8.35, 14.7) | 11.45 (7.77, 14.17) | 0.793 | |
| TP (60–80 g)/L | 64 (61, 70.5) | 63 (60, 68.5) | 0.178 | |
| Metabolism | GLU (3.9–6.1) mmol/L | 5.11 (4.68, 5.58) | 5.28 (4.68, 6.13) | 0.197 |
| TG (0.48–1.88) mmol/L | 1.44 (1.05, 1.97) | 1.38 (0.88, 1.72) | 0.406 | |
| TC < 5.18 mmol/L | 3.83 (3.12, 5.06) | 4.21 (3.21, 5.39) | 0.300 | |
| LDL (0.00–3.12) mmol/L | 2.18 (1.83, 2.78) | 2.53 (1.85, 3.45) | 0.084 | |
| HDL > 0.9 mmol/L | 1.05 (0.9, 1.24) | 1.03 (0.96, 1.21) | 0.588 | |
| SaO2 (95–100%) | 0.97 (0.95, 0.98) | 0.975 (0.97, 0.98) | 0.004** | |
| Blood routine | WBC (4–10) × 10^9/L | 6.37 (5.43, 8.08) | 7.28 (6.0, 9.67) | 0.039* |
| RBC (3.5–5.5) × 10^12/L | 4.51 ± 0.57 | 4.41 ± 0.51 | 0.189 | |
| HGB (110–160) g/L | 141.84 ± 17.75 | 139.31 ± 15.93 | 0.511 | |
| PLT (100–300) × 10^9/L | 207 (181, 242) | 199.5 (183.5, 232) | 0.768 | |
| RDW-SV (37-50fL) | 43 (40.5, 44.5) | 44 (41, 45) | 0.056 | |
| RDW-CV (11.5–14.5%) | 13 (12, 13) | 13 (12.25, 14) | 0.033* | |
| NEU (1.8–6.3) × 10^9/L | 4.04 (2.92, 5.44) | 5.2 (3.58, 7.69) | 0.005** | |
| LYM(1.1–3.2) × 10^9/L | 1.71 (1.45, 2.47) | 1.54 (1.1, 2.0) | 0.024* | |
| MON (0.1–0.6) × 10^9/L | 0.46 ± 0.18 | 0.49 ± 0.20 | 0.235 | |
| EOS (0.02–0.5) × 10^9/L | 0.1 (0.05, 0.18) | 0.075 (0.02, 0.15) | 0.240 | |
| BAS (0–0.06) × 10^9/L | 0.03 (0.02, 0.04) | 0.025 (0.02, 0.04) | 0.181 |
Normal + Low risk: Gensini score ≤ 20, Medium + High risk: Gensini points > 20; P . Normal + Low risk vs. Medium + High risk *P < 0.05, **P < 0.01.